MCR Labs Opens its First Facility Outside of Massachusetts
Image credit: MCR Labs
The analytical services of MCR Labs, one of Massachusetts’ larger cannabis testing companies, are now available in the state of Pennsylvania.
The new facility marks the company’s first expansion outside of Massachusetts.
Getting medical in Pennsylvania
As Pennsylvania does not legally permit recreational cannabis use, MCR’s new Allentown lab will only be testing medical marijuana samples.
“This is a huge step for us,” Michael Kahn, MCR’s president and founder, said in a statement. “We’re excited to be expanding and excited for the opportunity to carry out our mission of advancing public health and safety here in the Keystone State.”
Following its approval from the Pennsylvania Department of Health, MCR is the sixth medical cannabis testing lab in the state, joining the likes of Steep Hill Pennsylvania and Coral Reef Labs.
The facility is equipped to test samples for cannabinoids and terpenes, as well as impurities such as pesticides, residual solvents, heavy metals, microbes, mycotoxins, water activity, and moisture content.
Back in Massachusetts, MCR is one of three companies licensed to test medical marijuana, alongside ProVerde Laboratories and CDX Analytics.
Over the course of 2020, MCR reported a 38 percent increase in sample submissions. According to the company, 78 percent of these samples were from edibles and infused products, 28 percent were from cannabis flower, and 22 percent from vaporizer devices.
